Brokerages Set Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Price Target at $66.67
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Sun, 16 August 2026
What it is about
Geode Capital ManagementMillennium ManagementNewedge AdvisorsTopco LtdReviva PharmaceuticalsNasdaqLido AdvisorsNews Ratings For Reviva Pharmaceuticals DailyUnited StatesAnalyst Recommendations For Reviva PharmaceuticalsReviva Pharmaceuticals StockCoral Gables, Florida, United StatesFlorida, United States
Who published it, and when
How it spread - 1 original report
Sun, 16 August 2026
1 report- tickerreport.com05:58first to report
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) have received an average rating of “Hold” from the seven analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have given a buy recommendation […]